US · Healthcare

KYORIN Pharmaceutical Co., Ltd. (KYRNF)

Drug Manufacturers - Specialty & Generic

KYORIN Pharmaceutical Co., Ltd. (KYRNF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KYRNF

P/E ratio

18.00

KYORIN Pharmaceutical Co., Ltd. (KYRNF) — FAQ

What is KYRNF's P/E ratio?

The price-to-earnings (P/E) ratio for KYORIN Pharmaceutical Co., Ltd. (KYRNF) is 18.00 (data as of 2026-03-24).

Does KYORIN Pharmaceutical Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for KYORIN Pharmaceutical Co., Ltd. (KYRNF). Check the MyAverix Finance app for the latest dividend data.

What sector is KYORIN Pharmaceutical Co., Ltd. in?

KYORIN Pharmaceutical Co., Ltd. (KYRNF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is KYRNF listed on?

KYRNF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)